Clinical Trials Browser

Plasmablastic Lymphoma × Magnetic Resonance Spectroscopy × 90 days × Clear all

NCT07332507 2026-05-13

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

Phase 1 Not yet recruiting

Plasmablastic Lymphoma